Physician profile
Manish Kumar Varma
NPI 1669445631
$7,898.21
in general payments reported to CMS, 2019-2025
18 companies · $957 in 2025
The $957 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2021: $683 · 2022: $1,017 · 2023: $4,371 · 2024: $572 · 2025: $957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,000 · Food and Beverage: $2,118 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,000.00 |
| Food and Beverage | $2,117.76 |
| Travel and Lodging | $782.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $3,921.53 | 2023 | Trinav Infusion System |
| Inari Medical, INC. | $1,548.21 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $690.47 | 2019-2025 | Artix Mt, Flowtriever, Optablate |
| Sirtex Medical INC | $341.02 | 2019-2023 | Sir-Spheres Microspheres |
| Penumbra, INC. | $302.58 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $251.69 | 2023-2024 | Varian Cryocare Touch System |
| Medtronic, INC. | $179.87 | 2022-2025 | Concertotm |
| Boston Scientific Corporation | $170.46 | 2022-2025 | General - Interventional Oncology, Embold Fibered |
| Ethicon US, LLC | $134.11 | 2023 | Neuwave |
| Bard Peripheral Vascular, INC. | $125.61 | 2022 | |
| Cordis US Corp. | $64.22 | 2021-2025 | Mynx Control Venous, Mynxgrip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.64 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $34.61 | 2024 | |
| Cardinal Health 200 LLC | $18.96 | 2021 | |
| Depuy Synthes Sales INC. | $17.23 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $16.92 | 2025 | |
| Chiesi USA, INC. | $14.14 | 2025 | Cleviprex, Kengreal |
| Terumo Medical Corporation | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.